Loma Linda University Health, Loma Linda, CA, USA.
University of Washington, Seattle, WA, USA.
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241281612. doi: 10.1177/23247096241281612.
Anti-tubular basement membrane (anti-TBM) antibody nephritis is a rare type of tubulointerstitial nephritis associated with progressive decline in kidney function. It is characterized histopathologically by tubular atrophy and dilation, interstitial fibrosis, lymphocyte and macrophage-predominant cellular infiltration, and linear deposition of IgG and complement along the tubular basement membrane. We herein present a case of a 69-year-old male who was recently diagnosed with chronic lymphocytic leukemia (CLL) and was referred for evaluation of kidney failure, ultimately diagnosed as anti-TBM antibody nephritis progressing into end-stage kidney disease (ESKD). This case report highlights the management challenges of anti-TBM antibody nephritis as a rare kidney disorder.
抗肾小管基底膜 (anti-TBM) 抗体肾炎是一种罕见的肾小管间质性肾炎,与肾功能进行性下降有关。其组织病理学特征为肾小管萎缩和扩张、间质纤维化、以淋巴细胞和巨噬细胞为主的细胞浸润以及 IgG 和补体沿肾小管基底膜线性沉积。本文报告了一例 69 岁男性,近期诊断为慢性淋巴细胞白血病 (CLL),并因肾衰竭就诊,最终诊断为抗 TBM 抗体肾炎进展为终末期肾病 (ESKD)。本病例报告强调了抗 TBM 抗体肾炎作为一种罕见肾脏疾病的管理挑战。